These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7529925)

  • 1. Serotonergic control of androgen-induced dominance.
    Bonson KR; Johnson RG; Fiorella D; Rabin RA; Winter JC
    Pharmacol Biochem Behav; 1994 Oct; 49(2):313-22. PubMed ID: 7529925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of testosterone-induced dominance by the serotonergic agonist quipazine.
    Bonson KR; Winter JC
    Pharmacol Biochem Behav; 1992 Aug; 42(4):809-13. PubMed ID: 1513863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of serotonergic mechanisms in inhibition of isolation-induced aggression in male mice.
    Sánchez C; Arnt J; Hyttel J; Moltzen EK
    Psychopharmacology (Berl); 1993; 110(1-2):53-59. PubMed ID: 7870899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgens and estrogens modulate 5-HT1A and 5-HT1B agonist effects on aggression.
    Cologer-Clifford A; Simon NG; Richter ML; Smoluk SA; Lu S
    Physiol Behav; 1999 Jan 1-15; 65(4-5):823-8. PubMed ID: 10073487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postsynaptic 5-HT1 receptors and offensive aggression in rats: a combined behavioural and autoradiographic study with eltoprazine.
    Sijbesma H; Schipper J; de Kloet ER; Mos J; van Aken H; Olivier B
    Pharmacol Biochem Behav; 1991 Feb; 38(2):447-58. PubMed ID: 1829232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin receptors and animal models of aggressive behavior.
    Olivier B; Mos J; van Oorschot R; Hen R
    Pharmacopsychiatry; 1995 Oct; 28 Suppl 2():80-90. PubMed ID: 8614705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex.
    Dawson LA; Nguyen HQ; Smith DL; Schechter LE
    J Psychopharmacol; 2002 Jun; 16(2):145-52. PubMed ID: 12095073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain 5-HT and inhibition of aggressive behavior in animals: 5-HIAA and receptor subtypes.
    Miczek KA; Mos J; Olivier B
    Psychopharmacol Bull; 1989; 25(3):399-403. PubMed ID: 2483273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
    de Boer SF; Koolhaas JM
    Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo.
    Hjorth S; Pettersson G
    Eur J Pharmacol; 1993 Jul; 238(2-3):357-67. PubMed ID: 7691622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine.
    Wieland S; Kreider MS; McGonigle P; Lucki I
    Brain Res; 1990 Jun; 520(1-2):291-302. PubMed ID: 1698505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT1D receptors regulate 5-HT release in the rat raphe nuclei. In vivo voltammetry and in vitro superfusion studies.
    Piñeyro G; de Montigny C; Blier P
    Neuropsychopharmacology; 1995 Nov; 13(3):249-60. PubMed ID: 8602897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of fenfluramine and fluoxetine anorexia by 8-OH-DPAT is attenuated following raphe injection of 5,7-dihydroxytryptamine.
    Currie PJ; Coscina DV; Fletcher PJ
    Brain Res; 1998 Jul; 800(1):62-8. PubMed ID: 9685586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of sexual behavior of Long-Evans male rats by drugs acting on the 5-HT1A receptor.
    Rehman J; Kaynan A; Christ G; Valcic M; Maayani S; Melman A
    Brain Res; 1999 Mar; 821(2):414-25. PubMed ID: 10064829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
    Titeler M; Lyon RA; Davis KH; Glennon RA
    Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
    Misane I; Ogren SO
    Neuropsychopharmacology; 2000 Feb; 22(2):168-90. PubMed ID: 10649830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of galanin on 8-OH-DPAT induced decrease in body temperature and brain 5-hydroxytryptamine metabolism in the mouse.
    Patel S; Hutson PH
    Eur J Pharmacol; 1996 Dec; 317(2-3):197-204. PubMed ID: 8997601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.